HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Research analysts at Roth Capital raised their Q4 2026 earnings per share estimates for HIVE Blockchain Technologies in a research report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings of $0.04 per share for the quarter, up from their previous estimate of $0.03. Roth Capital currently has a “Strong-Buy” rating on the stock.
Other equities analysts also recently issued research reports about the stock. Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- 3 Healthcare Dividend Stocks to Buy
- Top 3 Stocks Goldman Sachs Predicts Will Dominate 2025
- 3 REITs to Buy and Hold for the Long Term
- Top 2 Auto Maintenance Stocks Gearing Up for 2025
- How to Calculate Inflation Rate
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
